Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Aemetis (AMTX)
NASDAQ:AMTX
AMTX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.93 - $7.03
Previous CloseN/A
Volume213.06K
Average Volume (3M)817.52K
Market Cap
$108.96M
Enterprise Value$559.50M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta3.48
Next Earnings
Mar 06, 2025EPS Estimate
-0.41Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.26
Shares Outstanding51,152,603
10 Day Avg. Volume803,366
30 Day Avg. Volume817,521
Standard Deviation0.45
R-Squared0.03
Alpha0.07
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.36
Price to Cash Flow (P/CF)-5.30
P/FCF Ratio33.80
Enterprise Value/Market Cap5.14
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit277.39
Enterprise Value/Ebitda-18.70
Forecast
1Y Price Target
$16.33Price Target Upside716.50% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4
---
Aemetis News
PremiumCompany Announcements
Aemetis Adjusts Executive Compensation and Bonuses
PremiumCompany Announcements
Aemetis Inc. Reports Q3 2024 Financial Results---
Bulls Say, Bears Say
Bulls Say
India OperationsThe company is continuing to deliver on its India operations with delivery of $103M of biodiesel to the three government-owned Oil Marketing Companies and receiving an initial $58M of new allocations for biodiesel supply.
Tax CreditsIRS tax credit approval underpins an important aspect of the company's future expected cash flow associated with the RNG business.
Bears Say
Financial PerformanceAemetis recently reported its fiscal Q2 2024 results with lower than expected revenue and EPS, indicating challenges in meeting financial targets.
---
Ownership Overview
8.57% Insiders
8.33% Mutual Funds
4.14% Other Institutional Investors
71.83% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
AMTX FAQ
What was Aemetis’s price range in the past 12 months?
Aemetis lowest stock price was $1.93 and its highest was $7.03 in the past 12 months.
What is Aemetis’s market cap?
Aemetis’s market cap is $108.96M.
When is Aemetis’s upcoming earnings report date?
Aemetis’s upcoming earnings report date is Mar 06, 2025 which is in 13 days.
How were Aemetis’s earnings last quarter?
Aemetis released its earnings results on Nov 12, 2024. The company reported -$0.38 earnings per share for the quarter, beating the consensus estimate of -$0.383 by $0.003.
Is Aemetis overvalued?
According to Wall Street analysts Aemetis’s price is currently Undervalued.
Does Aemetis pay dividends?
Aemetis does not currently pay dividends.
What is Aemetis’s EPS estimate?
Aemetis’s EPS estimate is -0.41.
How many shares outstanding does Aemetis have?
Aemetis has 51,152,603 shares outstanding.
What happened to Aemetis’s price movement after its last earnings report?
Aemetis reported an EPS of -$0.38 in its last earnings report, beating expectations of -$0.383. Following the earnings report the stock price went up 28.691%.
Which hedge fund is a major shareholder of Aemetis?
Currently, no hedge funds are holding shares in AMTX
---
Aemetis Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$16.33 (716.50% Upside)
$16.33 (716.50% Upside)
Blogger Sentiment
Bullish
AMTX Sentiment 75%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 3.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▲ 2.6%
Last 30 Days ▼ 3.6%
Last 30 Days ▼ 3.6%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-42.85%
12-Months-Change
Fundamentals
Return on Equity
37.38%
Trailing 12-Months
Asset Growth
-10.82%
Trailing 12-Months
Company Description
Aemetis
Aemetis, Inc. operates as a renewable fuels and biochemicals company. The firm focuses on the acquisition, development, and commercialization of technologies that replace traditional petroleum-based products by the conversion of ethanol and biodiesel plants into biorefineries. It operates through the North America and India segments. The North America segment comprises of the Keyes Plant in California, the cellulosic ethanol facility in Riverbank, the cluster of biogas digesters on dairies near Keyes, the Goodland Plant, and the research and development facility in Minnesota. The India segment includes the Kakinada plant, administrative offices in Hyderabad, and holding companies in Nevada and Mauritius. Its products include glycerin, ethanol, food and feed, biodiesel, and edible oils. The company was founded by Eric Armstrong McAfee in 2005 and is headquartered in Cupertino, CA.
---
AMTX Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mix of positive developments and challenges. Significant revenue growth and improvements in gross profit and operating loss highlight operational progress. However, increased interest expenses, a net income decline, and low cash reserves present financial challenges. Regulatory uncertainties regarding the 45Z tax credit and LCFS approval delays add complexity to future projections.Read More>---
AMTX Stock 12 Month Forecast
Average Price Target
$16.33
▲(716.50% Upside)
Technical Analysis
Archer Daniels Midland
―
Gevo
―
Green Plains
―
The Andersons
―
Bioceres Crop Solutions
―
Best Analysts Covering AMTX
1 Year
1 Year Success Rate
3/17 ratings generated profit
1 Year Average Return
-28.66%
reiterated a buy rating 2 months ago
Copying Amit Dayal's trades and holding each position for 1 Year would result in 17.65% of your transactions generating a profit, with an average return of -28.66% per trade.
---